Related Experiment Video
Updated: Jun 13, 2026
09:01
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Cancer and soluble FAS
S G Abbasova1, M M Vysotskii, L K Ovchinnikova
1M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Organic Biochemistry, Russian Academy of Sciences, Moscow, Russia. biochimia@mtu-net.ru
Bulletin of Experimental Biology and Medicine
|April 17, 2010
Summary
Serum soluble Fas (sFas) levels are elevated in cancer patients compared to healthy individuals. High sFas is linked to advanced cancer stages, poor differentiation, metastasis, and reduced survival in specific tumor types.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Soluble Fas (sFas) is a protein involved in apoptosis.
- Elevated sFas levels have been observed in various cancers, but its precise role and associations require further investigation.
Purpose of the Study:
- To measure serum sFas concentrations in patients with malignant and benign tumors.
- To evaluate the relationship between sFas levels and clinical-morphological characteristics of cancer.
Main Methods:
- Serum sFas concentrations were measured using a developed test system.
- Correlations between sFas levels and tumor characteristics were analyzed.
Main Results:
- Patients with tumors showed significantly higher serum sFas concentrations than healthy subjects.
- High sFas levels correlated with advanced disease stages, poor tumor differentiation, metastasis, and larger tumor size in several cancers.
- Elevated sFas was associated with reduced 5-year survival in osteosarcoma, endometrial, ovarian, and adrenocortical cancers.
- Thyroid cancer exhibited higher sFas than benign or hyperplastic thyroid conditions.
Conclusions:
- Serum sFas is a potential biomarker for tumor presence and progression.
- sFas levels correlate with adverse prognostic factors in various cancers.
- High sFas may indicate resistance to radiotherapy and poorer patient survival outcomes.
Related Concept Videos
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:25Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...